Global Pertussis Vaccine Market Research Report 2026

Pertussis Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pertussis Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global Pertussis Vaccine production reached approximately 350 million doses, with an average global market price of around US$ 16 per square meter. Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective. In this report, we cover all the pertussis-containing vaccines. Gross margin for the Pertussis vaccine in general shows that manufacturers often achieve roughly 50–70% gross margins, depending on the producer, country, and contract.

The global pertussis vaccine market continues to grow steadily, driven by rising awareness of whooping cough, expanding childhood immunization programs, and increasing recommendations for adolescent and adult Tdap boosters. Demand is especially strong in developing regions where pertussis remains endemic, while mature markets are supported by routine pregnancy immunization and periodic booster campaigns. Major manufacturers focus on improving vaccine safety, supply stability, and combination formulations such as DTaP, which simplify national immunization schedules. Although pricing and procurement are heavily influenced by government tenders and international organizations, overall market growth is supported by public-health initiatives, technological advances in acellular vaccine production, and efforts to increase global vaccination coverage. The pertussis vaccine industrial chain is a complex, highly regulated, and technology-intensive ecosystem that spans from upstream antigen research to downstream global immunization delivery. It is characterized by significant barriers to entry, stringent quality control, and a delicate balance between public health objectives and commercial viability. The chain begins with basic and applied research into Bordetella pertussis antigens. This includes the identification, genetic sequencing, and optimization of key immunogenic components such as Pertussis Toxin (PT), Filamentous Hemagglutinin (FHA), Pertactin (PRN), and Fimbrial proteins (FIM). For acellular vaccines (aP), the upstream segment involves mastering large-scale fermentation, toxin purification, and detoxification (converting PT to Toxoid) processes. This stage also encompasses the production of specialized adjuvants (e.g., aluminum salts) and critical raw materials for cell culture media and buffers. Innovation here focuses on improving antigen yield, purity, stability, and developing novel adjuvant systems to enhance and prolong immunity. The demand for pertussis vaccines is driven by the persistent prevalence of whooping cough, growing awareness of immunization benefits, and expanding vaccination programs for infants, adolescents, and adults. Rising adoption of Tdap boosters during pregnancy and among healthcare workers further fuels market growth. Opportunities exist in developing countries where vaccination coverage is still limited, as well as in urban areas of developed nations with increasing focus on adult immunization and combination vaccines like DTaP to simplify schedules. Additionally, technological innovations in acellular vaccine production, improvements in cold-chain logistics, and government-supported public health initiatives create potential for new market entrants and partnerships. Manufacturers that can offer safe, effective, and easily deployable vaccines, along with reliable supply chains, are well-positioned to capture market share in both emerging and mature markets.

This report delivers a comprehensive overview of the global Pertussis Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pertussis Vaccine. The Pertussis Vaccine market size, estimates, and forecasts are provided in terms of sales volume (M Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pertussis Vaccine market comprehensively. Regional market sizes by Type, by Application, by Composition, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pertussis Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Pertussis Vaccine Market Report

Chapter Outline

1.1 Product Definition

1.2 Pertussis Vaccine by Type

1.2.1 Global Pertussis Vaccine Market Value by Type: 2025 vs 2032

1.2.2 DTaP

1.2.3 Tdap

1.2.4 DTwP

1.3 Pertussis Vaccine by Composition

1.3.1 Global Pertussis Vaccine Market Value by Composition: 2025 vs 2032

1.3.2 Acellular Vaccines

1.3.3 Whole-cell Vaccines

1.4 Pertussis Vaccine by User

1.4.1 Global Pertussis Vaccine Market Value by User: 2025 vs 2032

1.4.2 Below 12 Months

1.4.3 Above 12 Months

1.5 Pertussis Vaccine by Application

1.5.1 Global Pertussis Vaccine Market Value by Application: 2025 vs 2032

1.5.2 Hospital

1.5.3 Clinic

1.6 Global Pertussis Vaccine Market Size Estimates and Forecasts

1.6.1 Global Pertussis Vaccine Revenue 2021–2032

1.6.2 Global Pertussis Vaccine Sales 2021–2032

1.6.3 Global Pertussis Vaccine Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2.1 Global Pertussis Vaccine Sales Market Share by Manufacturers (2021–2026)

2.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Pertussis Vaccine Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Pertussis Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Pertussis Vaccine, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Pertussis Vaccine, Product Types and Applications

2.7 Global Key Manufacturers of Pertussis Vaccine, Date of Entry into the Industry

2.8 Global Pertussis Vaccine Market Competitive Situation and Trends

2.8.1 Global Pertussis Vaccine Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Pertussis Vaccine Players Market Share by Revenue

2.8.3 Global Pertussis Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Pertussis Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Pertussis Vaccine Sales by Region: 2021–2032

3.2.1 Global Pertussis Vaccine Sales by Region: 2021–2026

3.2.2 Global Pertussis Vaccine Sales by Region: 2027–2032

3.3 Global Pertussis Vaccine Revenue by Region: 2021–2032

3.3.1 Global Pertussis Vaccine Revenue by Region: 2021–2026

3.3.2 Global Pertussis Vaccine Revenue by Region: 2027–2032

3.4 North America Pertussis Vaccine Market Facts & Figures by Country

3.4.1 North America Pertussis Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Pertussis Vaccine Sales by Country (2021–2032)

3.4.3 North America Pertussis Vaccine Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pertussis Vaccine Market Facts & Figures by Country

3.5.1 Europe Pertussis Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Pertussis Vaccine Sales by Country (2021–2032)

3.5.3 Europe Pertussis Vaccine Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pertussis Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Pertussis Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Pertussis Vaccine Sales by Region (2021–2032)

3.6.3 Asia Pacific Pertussis Vaccine Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pertussis Vaccine Market Facts & Figures by Country

3.7.1 Latin America Pertussis Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Pertussis Vaccine Sales by Country (2021–2032)

3.7.3 Latin America Pertussis Vaccine Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Pertussis Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Pertussis Vaccine Sales by Country (2021–2032)

3.8.3 Middle East and Africa Pertussis Vaccine Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Pertussis Vaccine Sales by Type (2021–2032)

4.1.1 Global Pertussis Vaccine Sales by Type (2021–2026)

4.1.2 Global Pertussis Vaccine Sales by Type (2027–2032)

4.1.3 Global Pertussis Vaccine Sales Market Share by Type (2021–2032)

4.2 Global Pertussis Vaccine Revenue by Type (2021–2032)

4.2.1 Global Pertussis Vaccine Revenue by Type (2021–2026)

4.2.2 Global Pertussis Vaccine Revenue by Type (2027–2032)

4.2.3 Global Pertussis Vaccine Revenue Market Share by Type (2021–2032)

4.3 Global Pertussis Vaccine Price by Type (2021–2032)

5.1 Global Pertussis Vaccine Sales by Application (2021–2032)

5.1.1 Global Pertussis Vaccine Sales by Application (2021–2026)

5.1.2 Global Pertussis Vaccine Sales by Application (2027–2032)

5.1.3 Global Pertussis Vaccine Sales Market Share by Application (2021–2032)

5.2 Global Pertussis Vaccine Revenue by Application (2021–2032)

5.2.1 Global Pertussis Vaccine Revenue by Application (2021–2026)

5.2.2 Global Pertussis Vaccine Revenue by Application (2027–2032)

5.2.3 Global Pertussis Vaccine Revenue Market Share by Application (2021–2032)

5.3 Global Pertussis Vaccine Price by Application (2021–2032)

6.1 Sanofi Pasteur

6.1.1 Sanofi Pasteur Company Information

6.1.2 Sanofi Pasteur Description and Business Overview

6.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio

6.1.5 Sanofi Pasteur Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Pertussis Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 GSK Pertussis Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Mitsubishi Tanabe Pharma

6.3.1 Mitsubishi Tanabe Pharma Company Information

6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview

6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio

6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates

6.4 KM Biologics

6.4.1 KM Biologics Company Information

6.4.2 KM Biologics Description and Business Overview

6.4.3 KM Biologics Pertussis Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 KM Biologics Pertussis Vaccine Product Portfolio

6.4.5 KM Biologics Recent Developments/Updates

6.5 Wuhan Institute of Biological Products

6.5.1 Wuhan Institute of Biological Products Company Information

6.5.2 Wuhan Institute of Biological Products Description and Business Overview

6.5.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio

6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates

6.6 Walvax Biotechnology

6.6.1 Walvax Biotechnology Company Information

6.6.2 Walvax Biotechnology Description and Business Overview

6.6.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio

6.6.5 Walvax Biotechnology Recent Developments/Updates

6.7 Chengdu Institute of Biological Products

6.7.1 Chengdu Institute of Biological Products Company Information

6.7.2 Chengdu Institute of Biological Products Description and Business Overview

6.7.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio

6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates

6.8 Minhai Biotechnology

6.8.1 Minhai Biotechnology Company Information

6.8.2 Minhai Biotechnology Description and Business Overview

6.8.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio

6.8.5 Minhai Biotechnology Recent Developments/Updates

7.1 Pertussis Vaccine Industry Chain Analysis

7.2 Pertussis Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pertussis Vaccine Production Mode & Process Analysis

7.4 Pertussis Vaccine Sales and Marketing

7.4.1 Pertussis Vaccine Sales Channels

7.4.2 Pertussis Vaccine Distributors

7.5 Pertussis Vaccine Customer Analysis

8.1 Pertussis Vaccine Industry Trends

8.2 Pertussis Vaccine Market Drivers

8.3 Pertussis Vaccine Market Challenges

8.4 Pertussis Vaccine Market Restraints

8.5 Impact of U.S. Tariffs

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Pertussis Vaccine Market Value by Type (US$ Million), 2025 vs 2032

 Table 2. Global Pertussis Vaccine Market Value by Composition (US$ Million), 2025 vs 2032

 Table 3. Global Pertussis Vaccine Market Value by User (US$ Million), 2025 vs 2032

 Table 4. Global Pertussis Vaccine Market Value by Application (US$ Million), 2025 vs 2032

 Table 5. Global Pertussis Vaccine Market Competitive Situation by Manufacturers in 2025

 Table 6. Global Pertussis Vaccine Sales (M Doses) of Key Manufacturers (2021–2026)

 Table 7. Global Pertussis Vaccine Sales Market Share by Manufacturers (2021–2026)

 Table 8. Global Pertussis Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)

 Table 9. Global Pertussis Vaccine Revenue Share by Manufacturers (2021–2026)

 Table 10. Global Market Pertussis Vaccine Average Price (USD/Doses) of Key Manufacturers (2021–2026)

 Table 11. Global Key Players of Pertussis Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

 Table 12. Global Key Manufacturers of Pertussis Vaccine, Manufacturing Sites and Headquarters

 Table 13. Global Key Manufacturers of Pertussis Vaccine, Product Types and Applications

 Table 14. Global Key Manufacturers of Pertussis Vaccine, Date of Entry into the Industry

 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 16. Global Pertussis Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pertussis Vaccine Revenue, 2025

 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 18. Global Pertussis Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 19. Global Pertussis Vaccine Sales by Region (M Doses), 2021–2026

 Table 20. Global Pertussis Vaccine Sales Market Share by Region (2021–2026)

 Table 21. Global Pertussis Vaccine Sales by Region (M Doses), 2027–2032

 Table 22. Global Pertussis Vaccine Sales Market Share by Region (2027–2032)

 Table 23. Global Pertussis Vaccine Revenue by Region (US$ Million), 2021–2026

 Table 24. Global Pertussis Vaccine Revenue Market Share by Region (2021–2026)

 Table 25. Global Pertussis Vaccine Revenue by Region (US$ Million), 2027–2032

 Table 26. Global Pertussis Vaccine Revenue Market Share by Region (2027–2032)

 Table 27. North America Pertussis Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 28. North America Pertussis Vaccine Sales by Country (M Doses), 2021–2026

 Table 29. North America Pertussis Vaccine Sales by Country (M Doses), 2027–2032

 Table 30. North America Pertussis Vaccine Revenue by Country (US$ Million), 2021–2026

 Table 31. North America Pertussis Vaccine Revenue by Country (US$ Million), 2027–2032

 Table 32. Europe Pertussis Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 33. Europe Pertussis Vaccine Sales by Country (M Doses), 2021–2026

 Table 34. Europe Pertussis Vaccine Sales by Country (M Doses), 2027–2032

 Table 35. Europe Pertussis Vaccine Revenue by Country (US$ Million), 2021–2026

 Table 36. Europe Pertussis Vaccine Revenue by Country (US$ Million), 2027–2032

 Table 37. Asia Pacific Pertussis Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

 Table 38. Asia Pacific Pertussis Vaccine Sales by Region (M Doses), 2021–2026

 Table 39. Asia Pacific Pertussis Vaccine Sales by Region (M Doses), 2027–2032

 Table 40. Asia Pacific Pertussis Vaccine Revenue by Region (US$ Million), 2021–2026

 Table 41. Asia Pacific Pertussis Vaccine Revenue by Region (US$ Million), 2027–2032

 Table 42. Latin America Pertussis Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 43. Latin America Pertussis Vaccine Sales by Country (M Doses), 2021–2026

 Table 44. Latin America Pertussis Vaccine Sales by Country (M Doses), 2027–2032

 Table 45. Latin America Pertussis Vaccine Revenue by Country (US$ Million), 2021–2026

 Table 46. Latin America Pertussis Vaccine Revenue by Country (US$ Million), 2027–2032

 Table 47. Middle East and Africa Pertussis Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 48. Middle East and Africa Pertussis Vaccine Sales by Country (M Doses), 2021–2026

 Table 49. Middle East and Africa Pertussis Vaccine Sales by Country (M Doses), 2027–2032

 Table 50. Middle East and Africa Pertussis Vaccine Revenue by Country (US$ Million), 2021–2026

 Table 51. Middle East and Africa Pertussis Vaccine Revenue by Country (US$ Million), 2027–2032

 Table 52. Global Pertussis Vaccine Sales (M Doses) by Type (2021–2026)

 Table 53. Global Pertussis Vaccine Sales (M Doses) by Type (2027–2032)

 Table 54. Global Pertussis Vaccine Sales Market Share by Type (2021–2026)

 Table 55. Global Pertussis Vaccine Sales Market Share by Type (2027–2032)

 Table 56. Global Pertussis Vaccine Revenue (US$ Million) by Type (2021–2026)

 Table 57. Global Pertussis Vaccine Revenue (US$ Million) by Type (2027–2032)

 Table 58. Global Pertussis Vaccine Revenue Market Share by Type (2021–2026)

 Table 59. Global Pertussis Vaccine Revenue Market Share by Type (2027–2032)

 Table 60. Global Pertussis Vaccine Price (USD/Doses) by Type (2021–2026)

 Table 61. Global Pertussis Vaccine Price (USD/Doses) by Type (2027–2032)

 Table 62. Global Pertussis Vaccine Sales (M Doses) by Application (2021–2026)

 Table 63. Global Pertussis Vaccine Sales (M Doses) by Application (2027–2032)

 Table 64. Global Pertussis Vaccine Sales Market Share by Application (2021–2026)

 Table 65. Global Pertussis Vaccine Sales Market Share by Application (2027–2032)

 Table 66. Global Pertussis Vaccine Revenue (US$ Million) by Application (2021–2026)

 Table 67. Global Pertussis Vaccine Revenue (US$ Million) by Application (2027–2032)

 Table 68. Global Pertussis Vaccine Revenue Market Share by Application (2021–2026)

 Table 69. Global Pertussis Vaccine Revenue Market Share by Application (2027–2032)

 Table 70. Global Pertussis Vaccine Price (USD/Doses) by Application (2021–2026)

 Table 71. Global Pertussis Vaccine Price (USD/Doses) by Application (2027–2032)

 Table 72. Sanofi Pasteur Company Information

 Table 73. Sanofi Pasteur Description and Business Overview

 Table 74. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)

 Table 75. Sanofi Pasteur Pertussis Vaccine Product

 Table 76. Sanofi Pasteur Recent Developments/Updates

 Table 77. GSK Company Information

 Table 78. GSK Description and Business Overview

 Table 79. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)

 Table 80. GSK Pertussis Vaccine Product

 Table 81. GSK Recent Developments/Updates

 Table 82. Mitsubishi Tanabe Pharma Company Information

 Table 83. Mitsubishi Tanabe Pharma Description and Business Overview

 Table 84. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)

 Table 85. Mitsubishi Tanabe Pharma Pertussis Vaccine Product

 Table 86. Mitsubishi Tanabe Pharma Recent Developments/Updates

 Table 87. KM Biologics Company Information

 Table 88. KM Biologics Description and Business Overview

 Table 89. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)

 Table 90. KM Biologics Pertussis Vaccine Product

 Table 91. KM Biologics Recent Developments/Updates

 Table 92. Wuhan Institute of Biological Products Company Information

 Table 93. Wuhan Institute of Biological Products Description and Business Overview

 Table 94. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)

 Table 95. Wuhan Institute of Biological Products Pertussis Vaccine Product

 Table 96. Wuhan Institute of Biological Products Recent Developments/Updates

 Table 97. Walvax Biotechnology Company Information

 Table 98. Walvax Biotechnology Description and Business Overview

 Table 99. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)

 Table 100. Walvax Biotechnology Pertussis Vaccine Product

 Table 101. Walvax Biotechnology Recent Developments/Updates

 Table 102. Chengdu Institute of Biological Products Company Information

 Table 103. Chengdu Institute of Biological Products Description and Business Overview

 Table 104. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)

 Table 105. Chengdu Institute of Biological Products Pertussis Vaccine Product

 Table 106. Chengdu Institute of Biological Products Recent Developments/Updates

 Table 107. Minhai Biotechnology Company Information

 Table 108. Minhai Biotechnology Description and Business Overview

 Table 109. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)

 Table 110. Minhai Biotechnology Pertussis Vaccine Product

 Table 111. Minhai Biotechnology Recent Developments/Updates

 Table 112. Key Raw Materials Lists

 Table 113. Raw Materials Key Suppliers Lists

 Table 114. Pertussis Vaccine Distributors List

 Table 115. Pertussis Vaccine Customers List

 Table 116. Pertussis Vaccine Market Trends

 Table 117. Pertussis Vaccine Market Drivers

 Table 118. Pertussis Vaccine Market Challenges

 Table 119. Pertussis Vaccine Market Restraints

 Table 120. Research Programs/Design for This Report

 Table 121. Key Data Information from Secondary Sources

 Table 122. Key Data Information from Primary Sources

 Table 123. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Pertussis Vaccine

 Figure 2. Global Pertussis Vaccine Market Value by Type (US$ Million), 2021–2032

 Figure 3. Global Pertussis Vaccine Market Share by Type: 2025 & 2032

 Figure 4. DTaP Product Picture

 Figure 5. Tdap Product Picture

 Figure 6. DTwP Product Picture

 Figure 7. Global Pertussis Vaccine Market Value by Composition (US$ Million), 2021–2032

 Figure 8. Global Pertussis Vaccine Market Share by Composition: 2025 vs 2032

 Figure 9. Acellular Vaccines Product Picture

 Figure 10. Whole-cell Vaccines Product Picture

 Figure 11. Global Pertussis Vaccine Market Value by User (US$ Million), 2021–2032

 Figure 12. Global Pertussis Vaccine Market Share by User: 2025 vs 2032

 Figure 13. Below 12 Months Product Picture

 Figure 14. Above 12 Months Product Picture

 Figure 15. Global Pertussis Vaccine Market Value by Application (US$ Million), 2021–2032

 Figure 16. Global Pertussis Vaccine Market Share by Application: 2025 & 2032

 Figure 17. Hospital

 Figure 18. Clinic

 Figure 19. Global Pertussis Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032

 Figure 20. Global Pertussis Vaccine Market Size (US$ Million), 2021–2032

 Figure 21. Global Pertussis Vaccine Sales (M Doses), 2021–2032

 Figure 22. Global Pertussis Vaccine Average Price (USD/Doses), 2021–2032

 Figure 23. Pertussis Vaccine Report Years Considered

 Figure 24. Pertussis Vaccine Sales Share by Manufacturers in 2025

 Figure 25. Global Pertussis Vaccine Revenue Share by Manufacturers in 2025

 Figure 26. Top 5 and Top 10 Global Pertussis Vaccine Players: Market Share by Revenue in Pertussis Vaccine in 2025

 Figure 27. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

 Figure 28. Global Pertussis Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Figure 29. North America Pertussis Vaccine Sales Market Share by Country (2021–2032)

 Figure 30. North America Pertussis Vaccine Revenue Market Share by Country (2021–2032)

 Figure 31. U.S. Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 32. Canada Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 33. Europe Pertussis Vaccine Sales Market Share by Country (2021–2032)

 Figure 34. Europe Pertussis Vaccine Revenue Market Share by Country (2021–2032)

 Figure 35. Germany Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 36. France Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 37. U.K. Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 38. Italy Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 39. Russia Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 40. Asia Pacific Pertussis Vaccine Sales Market Share by Region (2021–2032)

 Figure 41. Asia Pacific Pertussis Vaccine Revenue Market Share by Region (2021–2032)

 Figure 42. China Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 43. Japan Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 44. South Korea Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 45. India Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 46. Australia Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 47. Taiwan Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 48. Indonesia Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 49. Thailand Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 50. Malaysia Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 51. Philippines Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 52. Latin America Pertussis Vaccine Sales Market Share by Country (2021–2032)

 Figure 53. Latin America Pertussis Vaccine Revenue Market Share by Country (2021–2032)

 Figure 54. Mexico Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 55. Brazil Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 56. Argentina Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 57. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2021–2032)

 Figure 58. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2021–2032)

 Figure 59. Turkey Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 60. Saudi Arabia Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 61. U.A.E Pertussis Vaccine Revenue Growth Rate (US$ Million), 2021–2032

 Figure 62. Global Sales Market Share of Pertussis Vaccine by Type (2021–2032)

 Figure 63. Global Revenue Market Share of Pertussis Vaccine by Type (2021–2032)

 Figure 64. Global Pertussis Vaccine Price (USD/Doses) by Type (2021–2032)

 Figure 65. Global Sales Market Share of Pertussis Vaccine by Application (2021–2032)

 Figure 66. Global Revenue Market Share of Pertussis Vaccine by Application (2021–2032)

 Figure 67. Global Pertussis Vaccine Price (USD/Doses) by Application (2021–2032)

 Figure 68. Pertussis Vaccine Value Chain

 Figure 69. Channels of Distribution (Direct Vs Distribution)

 Figure 70. Bottom-up and Top-down Approaches for This Report

 Figure 71. Data Triangulation

 Figure 72. Key Executives Interviewed